101 – 110 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
The haematocrit - an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease
(
- Contribution to journal › Article
-
Mark
Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury
(
- Contribution to journal › Article
-
Mark
Response letter to: "Hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: Facts or technical artifacts?
(
- Contribution to journal › Letter
-
Mark
Shared and non-shared familial susceptibility of coronary heart disease, ischemic stroke, peripheral artery disease and aortic disease.
(
- Contribution to journal › Article
-
Mark
Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease
(
- Contribution to journal › Article
-
Mark
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study
(
- Contribution to journal › Article
-
Mark
Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS)
(
- Contribution to journal › Article
- 2012
-
Mark
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care
(
- Contribution to journal › Letter